107 related articles for article (PubMed ID: 35921662)
1. Arsenic Prodrug-Mediated Tumor Microenvironment Modulation Platform for Synergetic Glioblastoma Therapy.
Yan J; Hanif S; Zhang D; Ismail M; Wang X; Li Q; Shi B; Muhammad P; Wu H
ACS Appl Mater Interfaces; 2022 Aug; 14(32):36487-36502. PubMed ID: 35921662
[TBL] [Abstract][Full Text] [Related]
2. Tumor microenvironment-responsive nanozymes achieve photothermal-enhanced multiple catalysis against tumor hypoxia.
Lv W; Cao M; Liu J; Hei Y; Bai J
Acta Biomater; 2021 Nov; 135():617-627. PubMed ID: 34407474
[TBL] [Abstract][Full Text] [Related]
3. Boronic acid/boronate prodrugs for cancer treatment: current status and perspectives.
Maslah H; Pethe S; Labruère R
Future Med Chem; 2021 May; 13(10):859-861. PubMed ID: 33845596
[No Abstract] [Full Text] [Related]
4. Visible Light and Glutathione Dually Responsive Delivery of a Polymer-Conjugated Temozolomide Intermediate for Glioblastoma Chemotherapy.
Du K; Xia Q; Sun J; Feng F
ACS Appl Mater Interfaces; 2021 Dec; 13(47):55851-55861. PubMed ID: 34788006
[TBL] [Abstract][Full Text] [Related]
5. Functional Upgrading of an Organo-Ir(III) Complex to an Organo-Ir(III) Prodrug as a DNA Damage-Responsive Autophagic Inducer for Hypoxic Lung Cancer Therapy.
Wang MM; Deng DP; Zhou AM; Su Y; Yu ZH; Liu HK; Su Z
Inorg Chem; 2024 Mar; 63(10):4758-4769. PubMed ID: 38408314
[TBL] [Abstract][Full Text] [Related]
6. Nanocatalytic Theranostics with Glutathione Depletion and Enhanced Reactive Oxygen Species Generation for Efficient Cancer Therapy.
Fu LH; Wan Y; Qi C; He J; Li C; Yang C; Xu H; Lin J; Huang P
Adv Mater; 2021 Feb; 33(7):e2006892. PubMed ID: 33394515
[TBL] [Abstract][Full Text] [Related]
7. Aminoferrocene-based prodrugs activated by reactive oxygen species.
Hagen H; Marzenell P; Jentzsch E; Wenz F; Veldwijk MR; Mokhir A
J Med Chem; 2012 Jan; 55(2):924-34. PubMed ID: 22185340
[TBL] [Abstract][Full Text] [Related]
8. Facile Synthesis of Fe
Qi C; Wang W; Wang P; Cheng H; Wang X; Gong B; Xie A; Shen Y
Molecules; 2022 Jun; 27(13):. PubMed ID: 35807249
[TBL] [Abstract][Full Text] [Related]
9. Fusiform-Like Copper(II)-Based Metal-Organic Framework through Relief Hypoxia and GSH-Depletion Co-Enhanced Starvation and Chemodynamic Synergetic Cancer Therapy.
Wang Z; Liu B; Sun Q; Dong S; Kuang Y; Dong Y; He F; Gai S; Yang P
ACS Appl Mater Interfaces; 2020 Apr; 12(15):17254-17267. PubMed ID: 32227859
[TBL] [Abstract][Full Text] [Related]
10. Multimode Imaging-Guided Photothermal/Chemodynamic Synergistic Therapy Nanoagent with a Tumor Microenvironment Responded Effect.
Dong Y; Dong S; Wang Z; Feng L; Sun Q; Chen G; He F; Liu S; Li W; Yang P
ACS Appl Mater Interfaces; 2020 Nov; 12(47):52479-52491. PubMed ID: 33196186
[TBL] [Abstract][Full Text] [Related]
11. Microenvironment-driven sequential ferroptosis, photodynamic therapy, and chemotherapy for targeted breast cancer therapy by a cancer-cell-membrane-coated nanoscale metal-organic framework.
Pan WL; Tan Y; Meng W; Huang NH; Zhao YB; Yu ZQ; Huang Z; Zhang WH; Sun B; Chen JX
Biomaterials; 2022 Apr; 283():121449. PubMed ID: 35247637
[TBL] [Abstract][Full Text] [Related]
12. Glutathione-triggered nanoplatform for chemodynamic/metal-ion therapy.
Liu M; Wu H; Wang S; Hu J; Sun B
J Mater Chem B; 2021 Nov; 9(45):9413-9422. PubMed ID: 34746940
[TBL] [Abstract][Full Text] [Related]
13. The safe Laccase@ZIF-8-prodrug system with GSH redox cycle for effective targeted cancer therapy with low off-target toxicity.
Zhou Y; Zhang C; Wang Y; Zhang J; Yan X; You S; Qi W; Su R; He Z
Colloids Surf B Biointerfaces; 2022 Dec; 220():112853. PubMed ID: 36215892
[TBL] [Abstract][Full Text] [Related]
14. Oxygen-producing catalase-based prodrug nanoparticles overcoming resistance in hypoxia-mediated chemo-photodynamic therapy.
Cheng X; He L; Xu J; Fang Q; Yang L; Xue Y; Wang X; Tang R
Acta Biomater; 2020 Aug; 112():234-249. PubMed ID: 32502633
[TBL] [Abstract][Full Text] [Related]
15. Interactions of rat red blood cell sulfhydryls with arsenate and arsenite.
Winski SL; Carter DE
J Toxicol Environ Health; 1995 Nov; 46(3):379-97. PubMed ID: 7473865
[TBL] [Abstract][Full Text] [Related]
16. Bimetallic oxide nanozyme-mediated depletion of glutathione to boost oxidative stress for combined nanocatalytic therapy.
Li S; Ding H; Chang J; Dong S; Shao B; Dong Y; Gai S; He F; Yang P
J Colloid Interface Sci; 2022 Oct; 623():787-798. PubMed ID: 35636288
[TBL] [Abstract][Full Text] [Related]
17. Reactions of arsenic(III) and arsenic(V) species with glutathione.
Scott N; Hatlelid KM; MacKenzie NE; Carter DE
Chem Res Toxicol; 1993; 6(1):102-6. PubMed ID: 8448339
[TBL] [Abstract][Full Text] [Related]
18. Biodegradable BiOCl platform for oxidative stress injury-enhanced chemodynamic/radiation therapy of hypoxic tumors.
Liu Y; Zhang J; Du J; Song K; Liu J; Wang X; Li B; Ouyang R; Miao Y; Sun Y; Li Y
Acta Biomater; 2021 Jul; 129():280-292. PubMed ID: 34033970
[TBL] [Abstract][Full Text] [Related]
19. Photoactivation of Boronic Acid Prodrugs via a Phenyl Radical Mechanism: Iridium(III) Anticancer Complex as an Example.
Liu M; Luo Y; Yan J; Xiong X; Xing X; Kim JS; Zou T
J Am Chem Soc; 2023 May; 145(18):10082-10091. PubMed ID: 37098902
[TBL] [Abstract][Full Text] [Related]
20. Multifunctional carbon quantum dots as a theranostic nanomedicine for fluorescence imaging-guided glutathione depletion to improve chemodynamic therapy.
Li J; Hu ZE; We YJ; Liu YH; Wang N; Yu XQ
J Colloid Interface Sci; 2022 Jan; 606(Pt 2):1219-1228. PubMed ID: 34492460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
